| NCT04340063 | Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury | VA Office of Research and Development | | - Age 18 - 75 yrs
- Level C1-T10
AIS C, D- ≥ 6 months
- be able to ambulate 10 meters without any physical assistance (single cane, braces below the knee are permitted)
- be able to tolerate standing for 30 minutes.
- NOT use braces/orthotics crossing the knee joint
| Ended | 38 | NA | Rehabilitation | Standing/walking/mobility | | | 15 October 2020 | 09 April 2020 | 1 | |
| NCT04323449 | Evaluation of Vision-Guided Shared Control for Assistive Robotics Manipulators | VA Office of Research and Development | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 0 hours
- use a power wheelchair as primary means of mobility.
- have difficulties performing everyday tasks (e.g., reaching for water glass, picking up a toothbrush)
- NOT have impaired vision
- NOT have pressure ulcers that prevent sitting for extended periods of time
| Ended | 19 | NA | Technology | Arm/hand function | | | 13 April 2022 | 26 March 2020 | 1 | |
| NCT04309448 | Augmenting Reactive Stepping With FES After SCI | University Health Network, Toronto | | - Age ≥ 18 yrs
- Level C1-S5
AIS C, D- ≥ 1 years
- be able to stand independently for 60 seconds.
- be able to understand English.
- NOT have implanted device, e.g. pacemaker
| Ended | 2 | NA | Technology | Standing/walking/mobility | | | 01 September 2019 | 16 March 2020 | 1 | |
| NCT04307303 | Electrical Stimulation of Abdominal Muscles for Bowel Management in People With Spinal Cord Injury | Salisbury NHS Foundation Trust | | - Age ≥ 18 yrs
- Level C1-T11
AIS A, B, C, D- ≥ 1 years
- NOT have a history of organic bowel obstruction or inflammatory bowel disease
- NOT have implanted device, e.g. pacemaker
| Ended | 36 | NA | Technology | Bowel health | | | 07 July 2021 | 13 March 2020 | 1 | |
| NCT04302259 | Intelligent Spine Interface, Clinical (ISI-C) | Rhode Island Hospital | | - Age 18 - 65 yrs
- Level C7-T10
AIS A, B- 1 years - 65 years
- NOT have implanted drug pump or pacemaker device
| Active | 3 | NA | Technology | Standing/walking/mobility | | | 01 September 2021 | 10 March 2020 | 1 | |
| NCT04295538 | Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI) | AbbVie | | - Age 18 - 70 yrs
- Level C4-C7
AIS A, B- ≤ 24 hours
| Active | 60 | PHASE2 | Drug | Arm/hand function | | | 06 September 2020 | 04 March 2020 | 62 | |
